After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch
· thehindubusinessline.com
Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health
After an early lead in Semaglutide generics, Torrent Pharmaceuticals is now positioning itself for what could be a more differentiated play—bringing the US-ap...